MedPath

Improving clinical care of diabetes mellitus; randomized clinical trial

Conditions
Diabetes Mellitus
Registration Number
NL-OMON23763
Lead Sponsor
Government hospitalCommunity diabetes clinic
Brief Summary

In Process - Featuring Diabetic Care with Ascorbic Acid & Acetylsalicylic Acid; A Randomized Single Blind Control Trial

Detailed Description

Not available

Recruitment & Eligibility

Status
Other
Sex
Not specified
Target Recruitment
300
Inclusion Criteria

a. patient age more than 18years

b. diagnose with diabetes mellitus type 2 not more than 5 years

Exclusion Criteria

a. patient with age less than 18 years

b. diabetes history of more than 5 years

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
a. improved glucose tolerance <br /><br>b. Reduction in lipid profiling <br>
Secondary Outcome Measures
NameTimeMethod
a. Reduction in diabetes related complications over a period of 12 months<br /><br>b. Improved clinical outcomes in lipid profiling.<br /><br>c. comparison between Ascorbic acid Vs Acetylsalicylic acid combination with metformin.
© Copyright 2025. All Rights Reserved by MedPath